Opioids Market Growth, Trend, Price, Demand and Forecasts To 2025 Opioids Market - Global Industry Analysis, Size, S

Opioids Market - Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2017 – 2025
Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These
analgesics are used to manage pain in cancer patients and also to treat severe constant pain in patients
suffering from terminal illnesses. These are generally administered via subcutaneous, oral and
intramuscular routes; other routes of administration include nasal insufflations, patient controlled
analgesia, transdermal and oral mucosa routes via lozenges. Opioids can be classified into three major
classes namely, strong agonists (fentanyl, oxymorphone, and morphine), mild to moderate agonists
(codeine and hydroxycodone), and opioids with mixed receptor reactions (buprenophrine and
pentazocine). Although they form one of the most widely used analgesic classes, they cause certain
adverse effects such as constipation, nausea, vomiting, sedation, respiratory depression and others.
However, the major concern with this drug class is the high level of drug abuse observed worldwide,
leading to illegal trade of these drugs worth hundreds of billions of dollars. According to a study published
in the Journal of American Medical Association in April 2011, the rate of deaths occurring due to the
overdose of prescription opioids has increased substantially in the last decade in the U.S. alone. This study
also indicated that high doses of opioid drugs prescribed for pain management possessed increased risk
of overdose mortality in the patients.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22928
The leading molecules in this segment that constituted about 65% of the total opioids market include
OxyContin (oxycodone), Nucynta (tapentadol), Rybix and Ultram (tramadol), Exalgo (hydromorphone),
Ultiva (remifentanil) and fentanyl.The remaining 35% market revenue was contributed by other generic
opioids as well as combination formulations of NSAIDs with opioids.The actual market scenario for this
drug class, however, could be different due to the strong product pipeline, with two major entries
MoxDuo IR (morphine/oxycodone) and Remoxy (oxycodone) set to hit the market in 2016. The market
entry of these two drugs is expected to boost growth of the overall opioids market during the forecast
period. The number of patients suffering from chronic pain is on a constant rise globally. Thus, increasing
incidence of chronic pain conditions will continue to encourage the use of pain management drugs,
thereby driving the opioids market. Doctors usually prescribe medicines in the initial stages of pain,
followed by other treatment options. Prescription drugs are easy to use and economical and are expected
to support the growth of the opioids market globally. Prescription drug abuse is the major factor which
will limit the growth of the global opioids market.
The global opioids market has been segmented by type, geography, and distribution channel. The market
by type includes endogenous (enkephalins, endorphins), opium alkaloids, and synthetic and semisynthetic
opioids. The market for semisynthetic and synthetic opioids like fentanyl and oxycodone are expected to